Association of hospital‐treated infectious diseases and infection burden with cardiovascular diseases and life expectancy

医学 预期寿命 危险系数 置信区间 疾病 内科学 败血症 比例危险模型 传染病(医学专业) 环境卫生 人口
作者
Jiazhen Zheng,Can Ni,S. W. Ricky Lee,Fu‐Rong Li,Jinghan Huang,Rui Zhou,Yining Huang,Gregory Y.H. Lip,Xianbo Wu,Shaojun Tang
出处
期刊:Journal of Internal Medicine [Wiley]
卷期号:295 (5): 679-694
标识
DOI:10.1111/joim.13780
摘要

Abstract Background The association of a broad spectrum of infectious diseases with cardiovascular outcomes remains unclear. Objectives We aim to provide the cardiovascular risk profiles associated with a wide range of infectious diseases and explore the extent to which infections reduce life expectancy. Methods We ascertained exposure to 900+ infectious diseases before cardiovascular disease (CVD) onset in 453,102 participants from the UK Biobank study. Time‐varying Cox proportional hazard models were used. Life table was used to estimate the life expectancy of individuals aged ≥50 with different levels of infection burden (defined as the number of infection episodes over time and the number of co‐occurring infections). Results Infectious diseases were associated with a greater risk of CVD events (adjusted HR [aHR] 1.79 [95% confidence interval {CI} 1.74–1.83]). For type‐specific analysis, bacterial infection with sepsis had the strongest risk of CVD events [aHR 4.76 (4.35–5.20)]. For site‐specific analysis, heart and circulation infections posed the greatest risk of CVD events [aHR 4.95 (95% CI 3.77–6.50)], whereas noncardiac infections also showed excess risk [1.77 (1.72–1.81)]. Synergistic interactions were observed between infections and genetic risk score. A dose–response relationship was found between infection burden and CVD risks ( p ‐trend <0.001). Infection burden >1 led to a CVD‐related life loss at age 50 by 9.3 years [95% CI 8.6–10.3]) for men and 6.6 years [5.5–7.8] for women. Conclusions The magnitude of the infection‐CVD association showed specificity in sex, pathogen type, infection burden, and infection site. High genetic risk and infection synergistically increased the CVD risk.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
无辜的笙发布了新的文献求助10
1秒前
jgaigfuasfauv发布了新的文献求助10
1秒前
1秒前
yolo完成签到 ,获得积分10
1秒前
nini发布了新的文献求助10
2秒前
100w完成签到,获得积分10
2秒前
2秒前
十六发布了新的文献求助10
2秒前
杨汐菥完成签到,获得积分10
2秒前
2秒前
3秒前
眠羊完成签到,获得积分10
3秒前
YMH发布了新的文献求助10
3秒前
4秒前
5秒前
橘子完成签到,获得积分10
5秒前
5秒前
汤圆完成签到,获得积分10
5秒前
lynn完成签到,获得积分10
5秒前
Linda琳完成签到,获得积分10
6秒前
春市完成签到 ,获得积分10
6秒前
6秒前
vegetable完成签到,获得积分10
6秒前
Young离子完成签到 ,获得积分10
6秒前
ABCDE完成签到,获得积分10
7秒前
友好纹完成签到 ,获得积分10
7秒前
7秒前
先进的冰海完成签到,获得积分10
7秒前
小马甲应助zzq采纳,获得10
7秒前
Jesse完成签到,获得积分10
7秒前
顾枫完成签到,获得积分10
8秒前
8秒前
Owen应助jm采纳,获得10
8秒前
xmhxpz发布了新的文献求助10
8秒前
水牛发布了新的文献求助10
9秒前
冷静梦竹完成签到,获得积分10
9秒前
9秒前
MOFS完成签到,获得积分10
10秒前
Will发布了新的文献求助10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6952022
求助须知:如何正确求助?哪些是违规求助? 8636246
关于积分的说明 18312339
捐赠科研通 6394755
什么是DOI,文献DOI怎么找? 3082285
关于科研通互助平台的介绍 2127728
邀请新用户注册赠送积分活动 2059159